Screening and Prevention for CKD

Author(s):

Rajiv Agarwal, MD,Mark A. Meeker, DO, FACP, CPE

Key Takeaways

Identifying at-risk patients for CKD in Type 2 Diabetes involves assessing hypertension, family history, and blood glucose levels.
Screening tests for CKD include eGFR and UACR, essential for early detection in diabetic patients.
Early CKD detection allows timely intervention, slowing disease progression and reducing cardiovascular risks.
CKD is a significant risk factor for heart failure, highlighting the importance of early detection for cardiovascular risk management.

Panelists discuss the criteria for identifying at-risk patients for chronic kidney disease (CKD) testing in type 2 diabetes and review the screening and detection tests, emphasizing the critical importance of early detection through blood and urine tests for both CKD management and heart failure prevention.

What criteria should be used to identify at-risk patients for CKD testing in Type 2 Diabetes?
Can you review the screening and detection tests for CKD used in patients with diabetes patients?

Why is early detection of CKD through blood and urine tests so important? Why is it important from the perspective of heart failure?